Global Cell and Gene Therapy Bioassay Services Market Size is estimated to grow at a 25.0% CAGR during the forecast period for 2025 to 2034.
Cell and Gene Therapy Bioassay Services Market Size, Share & Trends Analysis Report By Type of Therapy (Cell Therapy, Gene Therapy), By Therapeutic Area, By Scale of Operation (Discovery, Preclinical, Clinical), By Region, And Segment Forecasts, 2025 to 2034
Cell and gene therapy focuses on modifying genetic material to improve functioning or treat a disease. These advanced therapies are one of the highest valued therapeutic segments within the biopharmaceutical industry and can address the most challenging diseases. Bioassay services play a critical role in the cell and gene therapy development process.
The key factors driving the growth of the cell and gene therapy bioassay services market include the high prevalence of chronic diseases and genetic disorders, the rising elderly population, the growing preference of patients toward personalized treatments, and increased technological advancements. Considering the demand for bioassays and the competitiveness of the biologics industry, many Drug developers prefer outsourcing bioanalytical services that offer bioassay services for quick and efficient therapy analysis and development. Likely to compel the growth opportunities for the cell and gene therapy bioassay services market in the coming years.
However, the expensive bioassay services offered by the contract research organizations (CROs) may hinder the market growth over the forecast period.
The cell and gene therapy bioassay services market are classified based on the type of therapy, therapeutic area, scale of operation, and region. By type of therapy, the market comprises cell therapy and gene therapy. The cell therapy segment is expected to hold the maximum market share in the coming days owing to the rising demand and awareness regarding cell therapies. The market is classified into oncological, infectious, autoimmune, rare/ genetic, cardiovascular, metabolic, blood, neurological, ophthalmic disorders, and other therapeutic areas in terms of therapeutic area. The oncological segment is expected to be the fastest-growing segment of this market in the coming years, owing to the high prevalence of cancer and the rising aging population. The scale of operation segment is grouped into discovery, preclinical, and clinical. Regionally, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is projected to dominate this market over the forecast period, followed by Europe and Asia-Pacific.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD XX Billion |
| Revenue Forecast In 2034 | USD XX Billion |
| Growth Rate CAGR | CAGR of 25.0% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type of Therapy, By Therapeutic Area, By Scale of Operation |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | AnaBioTec (Belgium), CCRM (Canada), Nexelis (Canada), Pacific BioLabs (US), PPD Laboratories (North Carolina), Intertek Pharmaceutical Services (UK), Lonza (Switzerland), Porton Biopharma Ltd (UK), WuXi Advanced Therapies (US), Avomeen (US), Charles River Laboratories (US), Absorption Systems (US), BioAgilytix Labs (US), Catalent, Inc (US), Svar Life Science AB (Sweden), and others. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.